Perspectiva general
This event will be conducted online via Zoom.
Click Here to View the Program
We are offering a reduced participation fee for attendees from outside Japan. To claim this rate, please complete the registration form (see program link above) and email to DIA Japan at: japan@diaglobal.org
Featured
Want to learn more about DIA Global Oncology Development 2021? You've come to the right site!
Comité del programa
-
Toshihiko Doi, MD, PHD Deputy Director / Chief, Experimental Therapeutics
National Cancer Center Hospital East, Japan -
Noboru Yamamoto, MD, PHD Deputy Director, Department of Experimental Therapeutics
National Cancer Center Hospital, Japan -
Masakazu Hirata, MD, PHD Clinical Reviewer, Division of RS Consultation, Kansai Branch
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Toshiko Ishibashi, PHD, RN Oncology Medical Science Department, Medical Affairs Division
Daiichi Sankyo Co., Ltd., Japan -
Eri Sekine Executive Vice President Data Business
CMIC Co., Ltd, Japan -
Takuya Suzuki Associate Director, Japan anad Asia Clinical Development Department
Eisai Co., Ltd., Japan -
Tomoko Takami Director, Oncology Clinical Development, Oncology Science Unit
MSD K.K., Japan -
Atsushi Tsukamoto, PHD, MSC Head is Therapeutic Area Strategies
Daiichi Sankyo, United States -
Hironobu Saito, PHD Specially Appointed Professor
Tottori University, Chromosome Egineering Research Center, Japan -
Junko Sato, PHD Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
¿Tiene una cuenta?